HDAC9 and neoplasm: In this work, we investigated the molecular mechanisms underlying the enhancement of the cytotoxic effect of etoposide under combined treatment with the HDAC inhibitor NaBut, which makes it possible to decrease drug concentrations while also maintaining their effectiveness in HDACi-sensitive and HDACi-resistant tumor cells.